Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?4.5 RB, SLActive? 14mm, RXD: medical device reports filed with FDA

1,044 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,044
device reports naming the brand
0% of all MAUDE reports · about 144 a year
230
reports, 12 months to August 2026
216 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,044 medical device reports received by FDA name the brand "BLX ?4.5 RB, SLActive? 14mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from April 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

230 reports arrived in the 12 months to August 2026, close to the 216 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (58.8%), loss of osseointegration (15.9%) and difficult to insert (1.9%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02243Sep 2021: 5Oct 2021: 19Nov 2021: 18Dec 2021: 72022Jan 2022: 16Feb 2022: 5Mar 2022: 7Apr 2022: 7May 2022: 16Jun 2022: 12Jul 2022: 5Aug 2022: 16Sep 2022: 13Oct 2022: 11Nov 2022: 18Dec 2022: 72023Jan 2023: 22Feb 2023: 7Mar 2023: 15Apr 2023: 5May 2023: 10Jun 2023: 15Jul 2023: 19Aug 2023: 15Sep 2023: 18Oct 2023: 33Nov 2023: 11Dec 2023: 82024Jan 2024: 8Feb 2024: 12Mar 2024: 9Apr 2024: 8May 2024: 15Jun 2024: 8Jul 2024: 22Aug 2024: 23Sep 2024: 18Oct 2024: 22Nov 2024: 16Dec 2024: 222025Jan 2025: 13Feb 2025: 14Mar 2025: 16Apr 2025: 13May 2025: 0Jun 2025: 43Jul 2025: 15Aug 2025: 24Sep 2025: 20Oct 2025: 27Nov 2025: 12Dec 2025: 262026Jan 2026: 11Feb 2026: 17Mar 2026: 26Apr 2026: 20May 2026: 11Jun 2026: 13Jul 2026: 23Aug 2026: 24

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01122232019: 2220192020: 5020202021: 11020212022: 13320222023: 17820232024: 18320242025: 22320252026: 1452026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,044
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report73.4%766
Voluntary report0%0
User facility report0%0
Distributor report26.6%278
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate61458.8%62.8%
Loss of osseointegration16615.9%22.4%
Difficult to insertthe device was hard to insert201.9%0.4%
Fracturea broken bone60.6%1.6%
Separation failure60.6%0.1%
Insufficient device problem information10.1%0.2%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis32431%
Painpain, site not specified23622.6%
Inflammationinflammation777.4%
Swelling/ edema585.6%
Tissue damage504.8%
Hemorrhage/blood loss/bleeding413.9%
Abscessa collection of pus383.6%
Fistula282.7%
Hyperresponsive to stimuli222.1%
Hypersensitivity/allergic reaction151.4%
Failure of implant70.7%
Inadequate osseointegration20.2%
Numbnessnumbness20.2%
Sinus perforation20.2%
Swellingswelling20.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?4.5 RB, SLActive? 14mm, RXDProduct code DZEAll MAUDE reports
Reports1,0443,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer73.4%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?4.5 RB, SLActive? 14mm, RXD reports

How many FDA reports name BLX ?4.5 RB, SLActive? 14mm, RXD?

1,044 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 230 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (58.8%), loss of osseointegration (15.9%), difficult to insert (1.9%), fracture (0.6%) and separation failure (0.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (73.4%) and distributor reports (26.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?4.5 RB, SLActive? 14mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.